JP2017222671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017222671A5
JP2017222671A5 JP2017130471A JP2017130471A JP2017222671A5 JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5 JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5
Authority
JP
Japan
Prior art keywords
compound
conjugate
protein
immunogenic carrier
ovalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017130471A
Other languages
English (en)
Japanese (ja)
Other versions
JP6423490B2 (ja
JP2017222671A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017222671A publication Critical patent/JP2017222671A/ja
Publication of JP2017222671A5 publication Critical patent/JP2017222671A5/ja
Application granted granted Critical
Publication of JP6423490B2 publication Critical patent/JP6423490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017130471A 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン Active JP6423490B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691454P 2012-08-21 2012-08-21
US61/691,454 2012-08-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015528568A Division JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018196525A Division JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Publications (3)

Publication Number Publication Date
JP2017222671A JP2017222671A (ja) 2017-12-21
JP2017222671A5 true JP2017222671A5 (enExample) 2018-02-22
JP6423490B2 JP6423490B2 (ja) 2018-11-14

Family

ID=49081007

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Country Status (11)

Country Link
US (1) US9303041B2 (enExample)
EP (2) EP2888269B1 (enExample)
JP (3) JP6171014B2 (enExample)
CN (1) CN104854110B (enExample)
AU (1) AU2013306018B2 (enExample)
CA (1) CA2882454C (enExample)
ES (2) ES2701062T3 (enExample)
PL (1) PL2888269T3 (enExample)
PT (1) PT2888269T (enExample)
TR (1) TR201816378T4 (enExample)
WO (1) WO2014031587A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
ES2701062T3 (es) * 2012-08-21 2019-02-20 Janssen Pharmaceutica Nv Haptenos de olanzapina
EP2888277A4 (en) 2012-08-21 2016-05-18 Ortho Clinical Diagnostics Inc ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
AU2013305970B2 (en) 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to aripiprazole haptens and use thereof
WO2014031645A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone haptens and use thereof
ES2654413T3 (es) 2012-08-21 2018-02-13 Janssen Pharmaceutica, N.V. Anticuerpos a quetiapina y uso de los mismos
WO2014031584A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Haptens of aripiprazole and their use in immunoassays
WO2014031662A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine and use thereof
ES3057437T3 (en) 2012-08-21 2026-03-02 Janssen Pharmaceutica Nv Antibodies to olanzapine haptens and use thereof
PL2888286T3 (pl) 2012-08-21 2018-07-31 Janssen Pharmaceutica Nv Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
ES2870004T3 (es) 2012-08-21 2021-10-26 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
PL2888373T3 (pl) 2012-08-21 2018-08-31 Janssen Pharmaceutica Nv Przeciwciała dla arypiprazolu i ich zastosowanie
CN108368180B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 喹硫平的抗体及其用途
JP6949025B2 (ja) 2015-12-17 2021-10-13 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンに対する抗体及びその使用
CN110938082A (zh) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 一种奥氮平人工抗原及其制备方法
CN110950808A (zh) * 2019-10-30 2020-04-03 杭州博拓生物科技股份有限公司 一种氯氮平人工抗原及其制备方法
EP4267187A1 (en) * 2020-12-22 2023-11-01 Intervet International B.V. Conjugated zearalenone to protect against mycotoxicosis
CN114685477B (zh) * 2020-12-25 2023-11-17 长沙博源医疗科技有限公司 一种利奈唑胺衍生物、免疫原、抗利奈唑胺特异性抗体及其制备方法与应用
CN114685527B (zh) * 2020-12-25 2024-03-05 长沙博源医疗科技有限公司 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
DE69329887T2 (de) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
EP0576095B1 (en) * 1992-06-26 1999-01-27 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays with labeled thyronine hapten analogues
US5395933A (en) * 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
EP1492794B1 (en) * 2002-03-28 2007-12-12 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
PT1664007E (pt) * 2003-09-23 2010-02-15 Fermion Oy Preparação de quetiapina
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
AU2005281359A1 (en) * 2004-08-26 2006-03-16 Apparao Satyam Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
JP2010540920A (ja) * 2007-09-27 2010-12-24 ノバルティス アーゲー 薬物モニタリングアッセイ
WO2010033270A1 (en) 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
TW201020258A (en) 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CN107714703A (zh) 2009-12-31 2018-02-23 凯姆制药公司 喹硫平的氨基酸缀合物、其制备和使用方法
RS58335B1 (sr) 2010-03-11 2019-03-29 Kempharm Inc Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
WO2013088255A1 (en) 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
ES2701062T3 (es) * 2012-08-21 2019-02-20 Janssen Pharmaceutica Nv Haptenos de olanzapina

Similar Documents

Publication Publication Date Title
JP2015532645A5 (enExample)
JP2018184433A5 (enExample)
JP2015181191A5 (enExample)
JP2018536572A5 (enExample)
RU2013133802A (ru) Стабильные и растворимые антитела, ингибирующие vegf
JP2019194236A5 (enExample)
JP2019524645A5 (enExample)
JP2017048194A5 (enExample)
JP2018100276A5 (enExample)
JP2021505614A5 (enExample)
JP2011511933A5 (enExample)
JP2009120624A5 (enExample)
JP2013539454A5 (enExample)
WO2018102315A8 (en) Polymorphs of sepiapterin and salts thereof
JP2012001634A5 (enExample)
RU2019110152A (ru) Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
JP2014521346A5 (enExample)
JP2016537293A5 (enExample)
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2014043437A5 (ja) 有機化合物
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
CO2017000010A2 (es) Proceso para la preparacion de ácidos 3-hidroxipicolínicos
MX2021014671A (es) Procedimiento para producir un aglutinante.
WO2015051079A3 (en) Phosphohistidine mimetics and antibodies to same
CN112262136A (zh) 一种吡咯并氨基哒嗪酮化合物的制备方法及其中间体